These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 8917680)
21. Essential role of Raf in Ras transformation and deregulation of matrix metalloproteinase expression in ovarian epithelial cells. Ulkü AS; Schäfer R; Der CJ Mol Cancer Res; 2003 Dec; 1(14):1077-88. PubMed ID: 14707291 [TBL] [Abstract][Full Text] [Related]
22. Raf and RhoA cooperate to transform intestinal epithelial cells and induce growth resistance to transforming growth factor beta. Du J; Jiang B; Coffey RJ; Barnard J Mol Cancer Res; 2004 Apr; 2(4):233-41. PubMed ID: 15140945 [TBL] [Abstract][Full Text] [Related]
23. Oncogenic Ras sensitizes normal human cells to tumor necrosis factor-alpha-related apoptosis-inducing ligand-induced apoptosis. Nesterov A; Nikrad M; Johnson T; Kraft AS Cancer Res; 2004 Jun; 64(11):3922-7. PubMed ID: 15173003 [TBL] [Abstract][Full Text] [Related]
24. Ha-ras oncogene expression abrogates a pH dependent endonuclease activity of apoptosis in normal rat kidney cells. Ostad M; Shu WP; Kong L; Liu BC Cancer Lett; 1996 Jan; 98(2):175-82. PubMed ID: 8556706 [TBL] [Abstract][Full Text] [Related]
25. The cell biology of ras-induced transformation: insights from studies utilizing an inducible hybrid oncogene system. Haliotis T; Trimble W; Chow S; Mills G; Girard P; Kuo JF; Govindji N; Hozumi N Anticancer Res; 1988; 8(5A):935-45. PubMed ID: 2845854 [TBL] [Abstract][Full Text] [Related]
26. Differential growth sensitivity to 4-cis-hydroxy-L-proline of transformed rodent cell lines. Ciardiello F; Sanfilippo B; Yanagihara K; Kim N; Tortora G; Bassin RH; Kidwell WR; Salomon DS Cancer Res; 1988 May; 48(9):2483-91. PubMed ID: 2833347 [TBL] [Abstract][Full Text] [Related]
27. Apoptosis mediates the selective toxicity of caffeic acid phenethyl ester (CAPE) toward oncogene-transformed rat embryo fibroblast cells. Su ZZ; Lin J; Prewett M; Goldstein NI; Fisher PB Anticancer Res; 1995; 15(5B):1841-8. PubMed ID: 8572568 [TBL] [Abstract][Full Text] [Related]
28. Differential induction of apoptosis in human breast tumor cells by okadaic acid and related inhibitors of protein phosphatases 1 and 2A. Kiguchi K; Glesne D; Chubb CH; Fujiki H; Huberman E Cell Growth Differ; 1994 Sep; 5(9):995-1004. PubMed ID: 7819137 [TBL] [Abstract][Full Text] [Related]
29. Characterization of a renal epithelial cell model of apoptosis using okadaic acid and the NRK-52E cell line. Davis MA; Smith MW; Chang SH; Trump BF Toxicol Pathol; 1994; 22(6):595-605. PubMed ID: 7732277 [TBL] [Abstract][Full Text] [Related]
30. The farnesyltransferase inhibitor FTI-277 radiosensitizes H-ras-transformed rat embryo fibroblasts. Bernhard EJ; Kao G; Cox AD; Sebti SM; Hamilton AD; Muschel RJ; McKenna WG Cancer Res; 1996 Apr; 56(8):1727-30. PubMed ID: 8620483 [TBL] [Abstract][Full Text] [Related]
31. Influence of cell type on the steroidogenic potential and basal cyclic AMP levels of ras-oncogene-transformed rat cells. Pan J; Roskelley CD; Auersperg N Differentiation; 1995 Jun; 58(5):321-8. PubMed ID: 7622009 [TBL] [Abstract][Full Text] [Related]
32. Early and late responses to induction of rasT24 expression in Rat-1 cells. Godwin AK; Lieberman MW Oncogene; 1990 Aug; 5(8):1231-41. PubMed ID: 2202952 [TBL] [Abstract][Full Text] [Related]
33. Detection of transforming ras proteins containing leucine at position 61 by a new mouse monoclonal antibody, ras(53-69)Leu61. Bizub D; Fischberg-Bender E; Heimer EP; Felix A; Skalka AM Cancer Res; 1989 Nov; 49(22):6425-31. PubMed ID: 2680065 [TBL] [Abstract][Full Text] [Related]
34. FK228 and oncogenic H-Ras synergistically induce Mek1/2 and Nox-1 to generate reactive oxygen species for differential cell death. Choudhary S; Rathore K; Wang HC Anticancer Drugs; 2010 Oct; 21(9):831-40. PubMed ID: 20700043 [TBL] [Abstract][Full Text] [Related]
35. Rod photoreceptor cell death is induced by okadaic acid through activation of PKC and L-type voltage-dependent Ca2+ channels and prevented by IGF-1. Adão-Novaes J; de Cássia Belem Guterrres C; Linden R; Sholl-Franco A Neurochem Int; 2010 Sep; 57(2):128-35. PubMed ID: 20466029 [TBL] [Abstract][Full Text] [Related]
36. Selective inhibition of the growth of ras-transformed human bronchial epithelial cells by emodin, a protein-tyrosine kinase inhibitor. Chan TC; Chang CJ; Koonchanok NM; Geahlen RL Biochem Biophys Res Commun; 1993 Jun; 193(3):1152-8. PubMed ID: 7686746 [TBL] [Abstract][Full Text] [Related]
37. Reversal of transformed phenotypes by herbimycin A in src oncogene expressed rat fibroblasts. Murakami Y; Mizuno S; Hori M; Uehara Y Cancer Res; 1988 Mar; 48(6):1587-90. PubMed ID: 3345529 [TBL] [Abstract][Full Text] [Related]
38. Effects of specific fatty acids on cell transformation induced by an activated c-H-ras oncogene. Hsiao WL; Pai HL; Matsui MS; Weinstein IB Oncogene; 1990 Mar; 5(3):417-21. PubMed ID: 2107493 [TBL] [Abstract][Full Text] [Related]
39. Effect of glucocorticoids on oncogene transformed NIH3T3 cells. Matin A; Cheng KL; Suen TC; Hung MC Oncogene; 1990 Jan; 5(1):111-6. PubMed ID: 2181373 [TBL] [Abstract][Full Text] [Related]
40. Functional identification and molecular cloning of a rat gene mediating growth inhibition and programmed cell death in normal and transformed rat cell lines. Schwarte-Waldhoff I; Martin W; Willecke K; Schäfer R Oncogene; 1994 Mar; 9(3):899-909. PubMed ID: 8108134 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]